［3］TebaldiM，HeadingＲC．Clinicaleconomicsreview:functional(non－ulcer)dyspepsia［J］．AlimentPharmacolTher，1998，12(1):11－19．［4］TalleyNJ．Therapeuticoptionsinnonulcerdyspepsia［J］．JClinGas-troenterol，2001，32:286－293．［5］PaulMoavyfdi．Whatistheoptimumstrategyformanagingdyspepsia?［J］．JGastroenterol，1998，33［SupplX］:44－47．［6］McCollE．Bestpracticeinsymptomassessment:Areview［J］．Gut，2004，53(Suppl4):iv49－iv54．［7］AFraser，DelaneyB，MoayyediP．Symptom－basedoutcomemeasuresfordyspepsiaandGEＲDtrials:asystematicreview［J］．AmJGastro-enterol，2005，100:442－52．［8］P．Moavyfdi，S．Duffett，D．Braunholtz，etal．TheLeedsDyspepsiaQuestionnaire:avalidtoolformeasuringthepresenceandseveritydys-pepsia［J］．AlimentPharmacolTher，1998，12:1257－1262．［9］A．Fraser，B．C．Delaney，A．C．Ford，etal．TheShort－FormLeedsDyspepsiaQuestionnairevalidationstudy［J］．AlimentPharmacolT-her，2007，25:477－486．［10］VeldhuyzenvanZantenSJ，TytgatKM．Canseverityofsymptomsbeusedasanoutcomemeasureintrialsofnon－ulcerdyspepsiaandHelicobacterpyloriassociatedgastritis?［J］．JClinEpidenmiol，1993，46:273－9．［11］B．Adam，T．Liebregts，K．Saadat－gliani，etal．Validationofthegas-trointestinalsymptomscorefortheassessmentofsymptomsinpatientswithfunctionaldyspepsia［J］．AlimentPharmacolTher，2005，22:357－363．［12］TallyNJ，FullertonS，JunghardO，elal．Qualityoflifeinpatients收稿日期:2013－06－26基金项目:南京市医学科技发展基金项目(YKK11049)作者简介:王振(1987－)，男，河南驻马店人，硕士研究生，研究方向:神经内科。通讯作者:王敬卿(1968－)，内蒙包头人，副教授、副主任医师，硕士研究生导师，研究方向:神经内科。withendoscopy－negativeheartburn:Ｒeliabilityandsensitivityofdisease－specificinstruments［J］．AmJGastroenterol，2001，96:1988－2004．［13］HuWH，LamKF，WongYH，etal．TheHongKongindexofdyspep-sia:Avalidatedsymptomseverityquestionnaireforpatientswithdys-pepsia［J］．JGastroenterolHepatol，2002，17:545－51．［14］TianXP，LiY，LiangFＲ，etal．TranslationandvalidationoftheNepeanDyspepsiaIndexforfunctionaldyspepsiainChina［J］．WorldJGastroenterol，2009，15(25):3173－3177．［15］EgglestonA，FarupC，MeierＲ．TheDomestic/InternationalGastro-enterologySurveillanceStudy(DIGEST):Design，subjectsandmeth-ods［J］．ScandJGastroenterolsuppl，1999，231:9－14．［16］SmitaL．S．Halder，NicholasJ．Talley．FunctionalDyspepsia:ANewＲomeIIIParadigm［J］．CurrentTreatmentOptionsinCardiovascularMedicine，2008，10(4):259－272．［17］HoltmannG，TalleyNJ，etal．Aplacebo－controlledtrialofitoprideinfunctionaldyspepsia［J］．NewEnglandJournalofMedicine，2006，354(8):832－840．［18］SanjivMahadeva，Khean－LeeGoh，etal．Anxiety，depressionandqualityoflifedifferencesbetweenfunctionalandorganicdyspepsia［J］．JournalofGastroenterologyandHepatology，2011，26Suppl(3):49－52．［19］SeyedAmirMirbagheri，NasimKhajavirad，etal．ImpactofHelico-bacterpyloriInfectionandMicroscopicDuodenalHistopathologicalChangesonClinicalSymptomsofPatientswithFunctionalDyspepsia［J］．DigDisSci，2012，57:967－972．［20］SanjivMahadeva，Wah－KheongChan．ValidationstudyoftheLeedsDyspepsiaQuestionnaireinamulti－ethnicAsianpopulation［J］．JournalofGastroenterologyandHepatology，2011，26:1669－1676．［21］LuigiGatta，PaulMoayyedi，etal．AvalidationstudyoftheItalianShort－FormLeedsDyspepsiaQuestionnaire［J］．InternEmergMed，2010，5:5...
